Literature DB >> 2676392

Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure.

Y Friedman1, C Franklin, E C Rackow, M H Weil.   

Abstract

Pneumocystis carinii pneumonia (PCP) causing acute respiratory failure (ARF) in patients with acquired immunodeficiency syndrome (AIDS) has been reported in several studies to have a mortality of 84 to 100 percent. A recent report found a 42 percent survival rate. We followed 58 patients with AIDS who required positive pressure ventilation and identified 33 patients with PCP and ARF who had a PaO2/FIo2 level less than 150 mmHg. We report the survival of 12 of these 33 (36 percent). The mean duration of survival after discharge from the hospital was 7.9 +/- 1.8 months, which is an improvement over previous reports. These data suggest that we should reevaluate the reported recommendations that patients with AIDS, PCP and ARF should not receive intensive care or mechanical ventilation.

Entities:  

Mesh:

Year:  1989        PMID: 2676392     DOI: 10.1378/chest.96.4.862

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  Purchasing care for people with HIV infection and AIDS.

Authors:  J Main; V Kitchen; S Lewis-Jones; V Moss
Journal:  Qual Health Care       Date:  1993-03

3.  Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe Pneumocystis carinii pneumonia.

Authors:  B Gachot; B Clair; M Wolff; B Régnier; F Vachon
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 4.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

5.  Intensive care for patients with the acquired immunodeficiency syndrome.

Authors:  J M Luce; R M Wachter
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

6.  Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.

Authors:  R F Miller; E Allen; A Copas; M Singer; S G Edwards
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

7.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

8.  Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.

Authors:  P Fernandez; A Torres; J M Miro; C Vieigas; J Mallolas; L Zamora; J M Gatell; M E Valls; R Riquelme; R Rodríguez-Roisin
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.